(Total Views: 429)
Posted On: 02/02/2021 11:40:26 AM
Post# of 148984
This is nothing new. Do you really believe a few hundred posters on a message board are going to counter a somewhat organized short attack on an OTC stock? A falling share price is a self-fulfilling prophecy. The companies have been sanctioned by the SEC time and again. Cytodyn doesn't have the time or the money to defend itself and either do we.
I'm not complaining about the posts. The concerns are legitimate. However, no short attack is going to overwhelm an FDA approval of the first therapeutic against COVID. No short attack is going to overwhelm approval of a simple, therapeutic against HIV. No short attack is going to overwhelm a real solution to deadly, triple-negative breast cancer.
To gain perspective we have to look down the road, just as if you are driving a car. If you look at the hood ornament (day to day activity), you will become disoriented. People have take Vyrologix and are alive or acquired a much improved quality of life because of it. To quote Dr. Patterson:
"An anecdote doesn't come off life support." This is the real battle. Getting Vyrologix out to the masses and saving lives. The share price will follow if...
I'm not complaining about the posts. The concerns are legitimate. However, no short attack is going to overwhelm an FDA approval of the first therapeutic against COVID. No short attack is going to overwhelm approval of a simple, therapeutic against HIV. No short attack is going to overwhelm a real solution to deadly, triple-negative breast cancer.
To gain perspective we have to look down the road, just as if you are driving a car. If you look at the hood ornament (day to day activity), you will become disoriented. People have take Vyrologix and are alive or acquired a much improved quality of life because of it. To quote Dr. Patterson:
"An anecdote doesn't come off life support." This is the real battle. Getting Vyrologix out to the masses and saving lives. The share price will follow if...
(6)
(0)
Scroll down for more posts ▼